Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,025.60
-27.00 (-1.32%)
Aug 6, 2025, 3:29 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 571.63 billion as of August 6, 2025. Its market cap has increased by 43.37% in one year.
Market Cap
571.63B
Enterprise Value
579.30B
Revenue
134.35B
Ranking
n/a
PE Ratio
54.60
Stock Price
2,025.60
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 571.63B, an increase of 49,636.74%. That is a compound annual growth rate of 29.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 579.25B | 27.57% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | 139.25B | 42.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,915.95B |
| Divi's Laboratories | 1,701.39B |
| Cipla | 1,211.47B |
| Mankind Pharma | 1,080.90B |
| Apollo Hospitals Enterprise | 1,045.89B |
| Zydus Lifesciences | 966.24B |
| Fortis Healthcare | 655.23B |
| Aurobindo Pharma | 626.86B |